Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Monogenic diabetes resulting from mutations that primarily reduce beta-cell function accounts for 1-2% of diabetes cases, although it is often misdiagnosed as either type 1 or type 2 diabetes. Knowledge of the genetic etiology of diabetes enables more-appropriate treatment, better prediction of disease progression, screening of family members and genetic counseling. We propose that the old clinical classifications of maturity-onset diabetes of the young and neonatal diabetes are obsolete and that specific genetic etiologies should be sought in four broad clinical situations because of their specific treatment implications. Firstly, diabetes diagnosed before 6 months of age frequently results from mutation of genes that encode Kir6.2 (ATP-sensitive inward rectifier potassium channel) or sulfonylurea receptor 1 subunits of an ATP-sensitive potassium channel, and improved glycemic control can be achieved by treatment with high-dose sulfonylureas rather than insulin. Secondly, patients with stable, mild fasting hyperglycemia detected particularly when they are young could have a glucokinase mutation and might not require specific treatment. Thirdly, individuals with familial, young-onset diabetes that does not fit with either type 1 or type 2 diabetes might have mutations in the transcription factors HNF-1alpha (hepatocyte nuclear factor 1-alpha) or HNF-4alpha, and can be treated with low-dose sulfonylureas. Finally, extrapancreatic features, such as renal disease (caused by muta…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, an exception is the mutational analyses established for classification of diabetes in the neonate (381-384) as well as in young individuals with a dominant family history of diabetes, often referred to as maturityonset diabetes of the young (MODY) (384,385) (Table 8).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [383]
In the citing paper
“Infants with neonatal diabetes due to a mutation in the KCNJ11 (potassium inwardly-rectifying channel, subfamily J, member 11; also known as KIR6.2) gene may be treated with sulfonylurea rather than with insulin (258,259).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
In the citing paper
“Genetic markers are currently of limited clinical value in evaluating and managing patients with diabetes; however, mutational analysis is rapidly emerging for classifying diabetes in the neonate (258-260) and in young patients with a dominant family history of diabetes, often referred to as “maturityonset diabetes of the young” (MODY) (261).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
Citations
Cites
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Goto, Y.-I., Nonaka, I., & Horai, S. (1990) · Nature · doi:10.1038/348651a0 · Cited by 2,070
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationChatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., & Bowcock, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11679 · Cited by 940
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“Currently, insulin remains the most common treatment during pregnancy for this patient group, but further studies are required to validate the safety and efficacy of sulfonylureas such as glibenclamide (also known as glyburide) that have least permeability through the placenta and have been used in gestational diabetes”
BackgroundEarly-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735 · cited 1×
“Most of those without diabetes have impaired fasting glucose levels”
Background
Research works printed but not linked: 1
- Pearson E et al. (2003) HDL-cholesterol: differentiating between HNF-1α MODY and type 2 diabetes [abstract]. Diabet Med 20 (Suppl 2): S1–S33
Cited by
Items 201–300 of 500
Carrillo, E., Lomas, A., Pinés, P. J., & Lamas, C. (2017) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-17-0052 · Cited by 16
The past 10 years—new hormones, new functions, new endocrine organs
Bouillon, R., Drucker, D. J., Ferrannini, E., Grinspoon, S. K., Rosen, C. J., & Zimmet, P. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.142 · Cited by 17
Diabetic ketoacidosis in the setting of HNF1A-maturity onset diabetes of the young
Egan, A. M., Cunningham, Á., Jafar‐Mohammadi, B., & Dunne, F. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-209163 · Cited by 18
The coexistence of type 1 diabetes, MODY2 and metabolic syndrome in a young girl
Calcaterra, V., Martinetti, M., Salina, A., Aloi, C., & Larizza, D. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0300-2 · Cited by 16
“The characteristics that define MODY include autosomal dominant inheritance, age (onset often before the age of 25), negative b-cell autoantibodies and insulin independence without signs of insulin-resistance [ 1 ].”
BackgroundInfluentialKomazec, J., Zdravković, V., Sajić, S., Ješić, M. D., Andjelković, M., Pavlović, S., & Ugrin, M. (2019) · Endokrynologia Polska · doi:10.5603/ep.a2018.0064 · Cited by 17
Bosma, A. R., Rigter, T., Weinreich, S. S., Cornel, M. C., & Henneman, L. (2015) · Diabetic Medicine · doi:10.1111/dme.12742 · Cited by 15
Wilmot-Roussel, H., Levy, D. J., Carette, C., Caillat‐Zucman, S., Boîtard, C., Timsit, J., & Dubois‐Laforgue, D. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.01.002 · Cited by 16
“Particularly, the diagnosis of NF1A- or HNF4A-MODY can lead to successful replacement f insulin therapy by sulfonylureas in patients initially misclasified as T1D [4].”
BackgroundChronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness
Průhová, Š., Dušátková, P., Kraml, P. J., Kulich, M., Prochazkova, Z., Brož, J., Zikmund, J., Cinek, O., Anděl, M., Pedersen, O. B., et al. (2013) · International Journal of Endocrinology · doi:10.1155/2013/718254 · Cited by 15
Yaghootkar, H., Abbasi, F., Ghaemi, N., Rabbani, A., Wakeling, M. N., Eshraghi, P., Enayati, S., Vakili, S., Heidari, S., Patel, K., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14071 · Cited by 19
Self-citationWaterfield, T., & Gloyn, A. L. (2008) · Pediatric Health · doi:10.2217/17455111.2.4.517 · Cited by 18
MODY probability calculator for GCK and HNF1A screening in a multiethnic background population
Tarantino, R. M., Abreu, G. D. M., Fonseca, A. C. P. D., Kupfer, R., Pereira, M. D. F. C., Campos, M., Zajdenverg, L., & Rodacki, M. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000173 · Cited by 19
“Our aim in this study was to estimate the frequency of MDM due to GCK or HNF1A mutations in patients with suggestive clinical characteristics and to investigate if the MODY probability calculator (MPC) could improve patient detection in this population (8,9).”
BackgroundCurtis, D. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3482 · Cited by 22
“Maturity onset diabetes of the young (MODY) is caused by mutations in a number of genes including HNF1A, HNF4A, GCK, HNF1B, KCNJ11, ABCC8.(3) Loss of function (LOF) and nonsynonymous variants in PPARG can cause a familial lipodystrophy with insulin resistant diabetes.”
BackgroundDellaManna, T., Dias-da-Silva, M. R., Chacra, A. R., Kunii, I. S., Rolim, A. L., Furuzawa, G. K., Maciel, R. M. B., & Reis, A. F. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000800005 · Cited by 16
MODY2 in Asia: analysis of GCK mutations and clinical characteristics
Zhou, Y., Wang, S., Wu, J., Dong, J., & Liao, L. (2020) · Endocrine Connections · doi:10.1530/ec-20-0074 · Cited by 17
Monogenic diabetes: An evidence-based clinical approach
Bhattacharya, S., Fernandez, C. J., Kamrul-Hasan, A. B. M., & Pappachan, J. M. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i5.104787 · Cited by 17
The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes
Owen, K. R., SKUPIEN, J. K., & Malecki, M. T. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(09)70004-x · Cited by 15
“nuclear factor-1β (HNF1B), as well as the glycolytic enzyme glucokinase (GCK), which cause maturity-onset diabetes of the young (MODY) and for the various genes which cause neonatal diabetes [3].”
BackgroundInfluentialLee, D., Kwak, S., Park, H. S., Ku, E. J., Jeon, H. J., & Oh, T. K. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002217 · Cited by 14
Østoft, S. H., Bagger, J. I., Hansen, T. F., Hartmann, B., Pedersen, O. B., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0070 · Cited by 18
Tatsi, C., Kanaka‐Gantenbein, C., Vazeou-Gerassimidi, A., Chrysis, D., Delis, D., Tentolouris, N., Dacou‐Voutetakis, C., Chrousos, G. P., & Sertedaki, A. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12032 · Cited by 17
“It is estimated that approximately 1–2% of the population with diabetes has MODY (4).”
BackgroundNeonatal diabetes and protein losing enteropathy: a case report
McMillan, T., Girgis, R., & Sellers, E. A. C. (2016) · BMC Medical Genetics · doi:10.1186/s12881-016-0296-0 · Cited by 14
“The most common underlying genetic causes of transient neonatal diabetes are due to imprinting defects of chromosome 6 [2].”
BackgroundInfluentialPhenotypic variability in two siblings with monogenic diabetes due to the same ABCC8 gene mutation
Cattoni, A., Jackson, C., Bain, M. D., Houghton, J., & Wei, C. H. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12826 · Cited by 15
Wirsing, A., Johnstone, K. A., Harries, L. W., Ellard, S., Ryffel, G. U., Staník, J., Gašperíková, D., Klimeś, I., & Murphy, R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03003.x · Cited by 14
Self-citationKlupa, T., Kozek, E., Nowak, N., Cyganek, K., Gach, A., Milewicz, T., Czajkowski, K., Tołłoczko, J., Mlynarski, W. M., & Malecki, M. T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0096 · Cited by 14
Michels, A. W., Jeffrey, J., & Eisenbarth, G. S. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_15 · Cited by 15
Sperling, M. A., Tamborlane, W. V., Battelino, T., WEINZIMER, S. A., & Phillip, M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00028-7 · Cited by 16
Stankov, K. (2010) · Journal of Medical Biochemistry · doi:10.2478/v10011-010-0016-9 · Cited by 9
“Based on these results, we anticipate that in some populations, or in particular subgroups of patients, monogenic causes of diabetes may largely exceed the estimation of 1–2%, with important consequences for diagnosis and patient management (69).”
BackgroundNaya, L. D., & Delgado, E. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.09.001 · Cited by 70
Alhaidan, Y., Christesen, H. T., Højlund, K., Balwi, M. A. A., & Brusgaard, K. (2020) · Molecular Genetics and Genomics · doi:10.1007/s00438-020-01695-5 · Cited by 13
Feng, X., Zhang, H., Yang, S., Cui, D., Wu, Y., Qi, X., & Su, Z. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-04999-x · Cited by 15
Distinct Regulation of Hepatic Nuclear Factor 1α by NKX6.1 in Pancreatic Beta Cells
Donelan, W., Koya, V., Li, S., & Yang, L.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064238 · Cited by 14
Xenopus as a model system for studying pancreatic development and diabetes
Kofent, J., & Spagnoli, F. M. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.01.005 · Cited by 14
Fu, J., Ping, F., Wang, T., Liu, Y., Wang, X., Yu, J., Deng, M., Liu, J. Y., Zhang, Q., Yu, M., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.05.002 · Cited by 13
Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects
Caetano, L. A., Jorge, A. A. L., Malaquias, A. C., Trarbach, E. B., Queiroz, M. S., Nery, M., & Teles, M. G. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000800010 · Cited by 13
“Hence, precise recognition of this disorder is very important for treatment decisions, and has relevant prognostic value (25).”
BackgroundMancusi, S., Manna, A. L., Bellini, G., Scianguetta, S., Roberti, D., Casale, M., Rossi, F., Ragione, F. D., & Perrotta, S. (2012) · Journal of Nephrology · doi:10.5301/jn.5000126 · Cited by 12
Genetic Architecture of Type 2 Diabetes
Prasad, R. B., & Groop, L. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch14 · Cited by 12
Ranjit Unnikrishnan, I., Radha, V., & Mohan, V. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s271582 · Cited by 13
Sperling, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00018-4 · Cited by 11
Özsu, E., Çizmecioğlu, F., Mutlu, G. Y., Yüksel, A., Calıskan, M., Yeşilyurt, A., & Hatun, Ş. (2018) · Hormone Research in Paediatrics · doi:10.1159/000494431 · Cited by 11
Strategies to identify individuals with monogenic diabetes: results of an economic evaluation
Peters, J., Anderson, R., Shields, B. M., King, S., Hudson, M., Shepherd, M. H., McDonald, T. J., Pearson, E. R., Hattersley, A. T., & Hyde, C. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034716 · Cited by 12
Self-citationIdentifying subtypes of monogenic diabetes
Juszczak, A., & Owen, K. R. (2013) · Diabetes Management · doi:10.2217/dmt.13.59 · Cited by 13
Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case report
Hilbrands, R., Keymolen, K., Michotte, A., Marichal, M., Cools, F., Goossens, A., Veld, P. I. '., Schepper, J. D., Hattersley, A. T., & Heimberg, H. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0419-2 · Cited by 12
Self-citationLenfant, C., Baz, P., Degavre, A., Philippi, A., Senée, V., Vandiedonck, C., Derbois, C., Nicolino, M. P., Zalloua, P., & Julier, C. (2017) · Genes · doi:10.3390/genes8110309 · Cited by 11
“Monogenic diabetes may account for 1–5% of all cases of diabetes [1,2], which is likely to be underestimated due to underdiagnosis.”
BackgroundNovel mutations in GCK and HNF1A genes in Italian families with MODY phenotype
Cappelli, A., Tumini, S., Consoli, A., Carinci, S., Piersanti, C., Ruggiero, G., Simonella, G., Soletti, F., Staffolani, P., & Pianese, L. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.007 · Cited by 9
Precision diabetes: Where do we stand today?
Mohan, V., & Unnikrishnan, R. (2018) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1628_18 · Cited by 13
Where to for precision treatment of HNF1A-MODY?
Bonner, C., & Saponaro, C. (2022) · Diabetologia · doi:10.1007/s00125-022-05696-4 · Cited by 11
Neonatal diabetes mellitus: current perspective
Shah, B. C., Kataria, A., Gopi, R. P., & Mally, P. (2014) · Research and Reports in Neonatology · doi:10.2147/rrn.s38206 · Cited by 18
“11,14 In a minority of patients, PNDM secondary to K ATP channel mutations has also been associated with neurological features, representing the most severe clinical form of PNDM, Developmental delay, Epilepsy, and Neonatal Diabetes (DEND) syndrome.”
Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes
Peters, J., Anderson, R., & Hyde, C. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002905 · Cited by 12
Li, Q., Cao, X., Qiu, H., Lü, J., Gao, R., Liu, C., Yuan, M.-X., Yang, G.-R., & Yang, J. (2016) · Gene · doi:10.1016/j.gene.2016.05.021 · Cited by 12
Madani, H. A., Fawzy, N., Afif, A., Abdelghaffar, S., & Gohar, N. (2016) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2016.157 · Cited by 10
Genes predisposing to neonatal diabetes mellitus and pathophysiology: Current findings
Yahaya, T., & Anyebe, D. (2020) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-190353 · Cited by 14
Whole exome sequencing reveals novel candidate gene variants for MODY
Çapan, Ö. Y., Aydın, N., Yilmaz, T. M., & Berber, E. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.005 · Cited by 9
Diabetes Mellitus With Renal and Müllerian Anomalies
Agarwal, K., Chapla, A., Chandramohan, A., Singh, C. J., Thomas, N., & Jebasingh, F. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2021.06.012 · Cited by 12
Rungby, J., Steffensen, Thomsen, R. W., Vaag, A. A., Beck‐Nielsen, H., & Christiansen (2012) · Clinical Epidemiology · doi:10.2147/clep.s30188 · Cited by 10
Yıldız, M., Akçay, T., Aydın, B. K., Akgün, A., Doğan, B. B., Franco, E. D., Ellard, S., & Önal, H. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0325 · Cited by 10
“Depending on the duration of insulin requirement early in the first months/years of life, it can be either classified as permanent (PNDM) or transient (TNDM), which is characterized by a remitting phase frequently followed by a relapse [2].”
BackgroundSelf-citationGenetics: how the UKPDS contributed to determining the genetic landscape of Type 2 diabetes
Gloyn, A. L., & McCarthy, M. I. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02500.x · Cited by 12
Cabezas, Ó. R., & Argente, J. (2012) · Anales de Pediatría · doi:10.1016/j.anpedi.2012.06.013 · Cited by 25
The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent
Gozlan, Y., Tenenbaum, A., Shalitin, S., Lebenthal, Y., Oron, T., Cohen, O., Phillip, M., & Gat‐Yablonski, G. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00822.x · Cited by 9
“MODY2 and MODY3 due to mutations in genes encoding the enzyme GCK and the transcription factor HNF1α, respectively, are the most common, and the other subtypes are rare (8).”
BackgroundManagement of Diabetes in Children
Wolfsdorf, J. I., & Garvey, K. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00049-4 · Cited by 13
From glucose sensing to exocytosis: takes from maturity onset diabetes of the young
Samadli, S., Zhou, Q.-L., Zheng, B., Gu, W., & Zhang, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1188301 · Cited by 8
Type 2 diabetes genes – Present status and data from Norwegian studies
Hertel, J. K., Johansson, S., Midthjell, K., Nygard, O. K., Njølstad, P. R., & Molven, A. (2013) · Norsk Epidemiologi · doi:10.5324/nje.v23i1.1597 · Cited by 14
Current Insights into the Genetic Basis of Diabetes Mellitus in Children and Adolescents
Rubio‐Cabezas, O., & Argente, J. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.10.917 · Cited by 13
Buerck, L. W., Schuster, M., Rathkolb, B., Sabrautzki, S., de Angelis, M. H., Wolf, E., Aigner, B., Wanke, R., & Herbach, N. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.001 · Cited by 9
Molecular genetics of maturity-onset diabetes of the young
Voevoda, M. I., Иванова, А. А., Шахтшнейдер, Е. В., Ovsyannikova, A. K., Михайлова, С. В., Астракова, К. С., Воевода, С. М., & Rymar, O. D. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh2016884117-124 · Cited by 10
“В дальнейшем MODY стали классифицировать как генетически обусловленный СД с дефектом функционирования β-клеток ПЖ [8].”
Magaña‐Cerino, J. M., Luna‐Arias, J. P., Labra‐Barrios, M. L., Avendaño‐Borromeo, B., Boldo‐León, X. M., & Martínez‐López, M. C. (2016) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.261 · Cited by 12
“Penetrance of diabetes in patients with mutations in MODY is quite high (more than 95% by the age of 55 years) (Frayling et al. 2001; Murphy et al. 2008).”
BackgroundTsoi, S. T. F., Lim, C. K. P., Ronald, C. W., Lau, E. S. H., Fan, B., Chow, E., Kong, A. P. S., Chan, J. C. N., & Luk, A. O. Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3823 · Cited by 11
“20,49,50 It is possible that patients with CNV in HNF1B were not detected using the CNV detection algorithm resulting in underestimation of HNF1B ‐ MODY.”
Kavitha, B., Ranganathan, S., Gopi, S., Vetrivel, U., Nagarajan, H., Mohan, V., & Venkatesan, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1177268 · Cited by 12
Permanent Neonatal Diabetes Mellitus Due to an ABCC8 Mutation: A Case Report
Abraham, N., Ahamed, A., Unnikrishnan, A., Kumar, H., & Ellard, S. (2014) · PubMed · doi:10.6092/1590-8577/1947 · Cited by 9
“Other rare genetic causes of neonatal diabetes include mutations in insulin gene (INS), hepatocyte nuclear factor 1B (HNF1B), pancreatic and duodenal homeobox 1(PDX 1), pancreas specific transcription 2 factor, 1a (PTF1A), forkheadbox P3 (FOXP3), eukaryotic translation initiation factor 2alpha kinase 3 (EIF2AK3), and…”
BackgroundSelf-citationKaraca, E., Önay, H., Çetinkalp, Ş., Aykut, A., Gökşen, D., Özen, S., Atık, T., Darcan, Ş., Tekin, İ. M., & Özkınay, F. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.042 · Cited by 8
Mutations in HNF1A Gene are not a Common Cause of Familial Young-Onset Diabetes in Iran
Moghbeli, M., Naghibzadeh, B., Ghahraman, M., Fatemi, S., Taghavi, M., Vakili, R., & Abbaszadegan, M. R. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0648-3 · Cited by 7
GCK-MODY diabetes course in persons over 18 years of age: prospective observation
Ovsyannikova, A. K., Шахтшнейдер, Е. В., Иванощук, Д. Е., Voevoda, M. I., & Rymar, O. D. (2021) · Diabetes Mellitus · doi:10.14341/dm12319 · Cited by 11
Ng, N., Zamuner, M. B. M., Siddique, N., Kim, J. M., Burke, M., & Byrne, M. M. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01794-8 · Cited by 8
Costa‐Riquetto, A. D., de Santana, L. S., Franco, P. C., Junior, A. C. S., Martio, A. E., Lisboa, H. R. K., Kohara, S. K., & Teles, M. G. (2022) · Clinical Genetics · doi:10.1111/cge.14279 · Cited by 8
“Additionally, molecular diagnosis enables genetic counseling to be performed, allowing recurrence in siblings and descendants of index cases to be predicted.(5) Since this is a rare disease, few studies have been conducted on NDM and EOD in Brazil.”
BackgroundMašindová, I., Varga, L., Staník, J., Valentínová, L., Profant, M., Klimeś, I., & Gašperíková, D. (2012) · Endocrine Regulations · doi:10.4149/endo_2012_03_167 · Cited by 9
“The lactate accumulation is caused by mitochondrial damage and metabolism in anaerobic conditions (Murphy et al. 2008).”
BackgroundKhelifa, S. B., Dendana, A., Barboura, I., Khochtali, I., Chahed, H., Ferchichi, S., & Miled, A. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.01.015 · Cited by 8
Zou, Y., Wang, Y., Zhang, S., Wu, Y., & Liu, X. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800136 · Cited by 10
Do genome-wide association scans have potential for translation?
Lopes, M. C., Zeggini, E., & Panoutsopoulou, K. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.748 · Cited by 9
Шахтшнейдер, Е. В., Михайлова, С. В., Иванощук, Д. Е., Orlov, P. S., Ovsyannikova, A. K., Rymar, O. D., Ragino, Y. I., & Voevoda, M. I. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3338-1 · Cited by 8
“This type of diabetes differs from classic types of diabetes mellitus—type 1 (DM1) and type 2 (DM2)—in disease progression, in treatment strategies, and prognosis [1].”
Corrales, P. J. P., López-Garrido, M.-P., Rodríguez, S. A., Rubio, L. L., Jiménez, L. M. L., Lamas, C., Martínez, J. J. A., García, J. J. L., López, A. H., Castillo, R. R., et al. (2010) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(10)70002-4 · Cited by 8
Corrao, S., & Federici, M. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02556-6 · Cited by 8
“Its clinical recognition is essential, as specific subtypes may respond well to sulfonylureas rather than insulin [4, 5].”
Silvestri, F. (2016) · Pediatrics & Therapeutics · doi:10.4172/2161-0665.1000274 · Cited by 6
“However, our patient is the first case of TNDM induced by substitution of L225P in ABCC8 gene reported in literature [19-28].”
BackgroundThe Etiological Diagnosis of Diabetes: Still a Challenge for the Clinician
Dubois‐Laforgue, D., & Timsit, J. (2023) · Endocrines · doi:10.3390/endocrines4020033 · Cited by 8
“Correlations between a patient’s phenotype and the involved gene have been reported [78], but are questioned by the heterogenous phenotypes observed in patients harboring abnormalities of the same gene, and by the overlap of the diabetes phenotypes associated with different genes [79] (Figure 3).”
BackgroundFailure of TRIGR Study Opens Door to Alternative Explanation of T1DM Etiopathology
Dow, C. T. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000e112 · Cited by 6
Diagnose und Behandlung des Maturity-Onset Diabetes of the Young (MODY)
Emmelheinz, M., Knebel, B., & Müssig, K. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-0785-0482 · Cited by 7
Report of Prolonged Neonatal Hypoglycemia in Three Infants of Mothers With Variants in HNF1A
CROMER, S. J., Sella, A. C., Rosenberg, E., Scully, K. J., McDonnell, M. E., Abreu, A. P., Weil, M., Bernstein, S. N., Quinn, M., Powe, C. E., et al. (2022) · AACE Clinical Case Reports · doi:10.1016/j.aace.2022.07.004 · Cited by 7
Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age
Jones, A. G., & Hattersley, A. T. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.42 · Cited by 7
Self-citationStress Hyperglycemia: A Sign of Familial Diabetes in Children
Oron, T., Gat‐Yablonski, G., Lazar, L., Phillip, M., & Gozlan, Y. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3193 · Cited by 7
Monogenic forms of diabetes mellitus: an update
Vaxillaire, M., & Froguel, P. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)73513-2 · Cited by 8
“and NEUROD1/beta2 (MODY6), and the preproinsulin ( INS , MODY7) 1,6,11,12 .”
InfluentialSechko, E. A., Кураева, Т. Л., Zilberman, L. I., Иванова, О. Н., & Peterkova, V. A. (2015) · Problems of Endocrinology · doi:10.14341/probl201561316-22 · Cited by 10
21‐Year‐Old Pregnant Woman with MODY‐5 Diabetes
Mikuscheva, A., McKenzie, E., & Mekhail, A. (2017) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2017/6431531 · Cited by 10
Wang, X., Wang, F., Wu, H., Chen, X., Xie, R., Chen, T., Sun, H., Zhang, D., & Chen, L. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8579 · Cited by 7
“This variant has been reported previously and it is pathogenic (14,26,27).”
BackgroundEstévez, P., Boscolo, O., Quiroga, E., Penuto, R. F., Buontempo, F., Tripodi, V. P., & Lucangioli, S. E. (2015) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2015-000763 · Cited by 7
A Systematic Review of the use of Precision Diagnostics in Monogenic DiabetesPreprint
Murphy, R., Colclough, K., Pollin, T., Ikle, J. M., Svalastoga, P., Maloney, K. A., Saint-Martin, C., Molnes, J., Misra, S., Aukrust, I., et al. (2023) · medRxiv · doi:10.1101/2023.04.15.23288269 · Cited by 3
Self-citationMonogenic diabetes mellitus in cystic fibrosis
Gan, H., Bhatt, J., Denvir, L., Randell, T. L., & Sachdev, P. (2018) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316141 · Cited by 7
Transient Neonatal Diabetes Mellitus and Seizure with an Unknown Etiology
Güneş, S. O., Çalışıcı, E., Arslan, M., Akın, O., & Karagöl, B. S. (2021) · Journal of Pediatric Genetics · doi:10.1055/s-0041-1727175 · Cited by 7
Neonatal and early‐onset diabetes in Ukraine: Atypical features and mortality
Globa, E., Zelinska, N., Johnson, M. B., Flanagan, S. E., & Franco, E. D. (2022) · Diabetic Medicine · doi:10.1111/dme.15013 · Cited by 6
Sabin, M. A. (2013) · Clinical Obesity · doi:10.1111/cob.12020 · Cited by 6
“Furthermore, some types of monogenic beta-cell diabetes (previously termed maturity onset diabetes of the young) have a definite clinical overlap with type 2 diabetes, leading to further confusion in those families with a strong ‘autosomal dominant’ pattern of diabetes (16).”
BackgroundGenetic Determinants Predicting Efficacy of Glucose-Lowering Drugs?
Nauck, M. A., & Vardarli, I. (2010) · Diabetes Care · doi:10.2337/dc10-1263 · Cited by 6
Optimizing maturity‐onset diabetes of the young detection in a pediatric diabetes population
Menon, S., REFAEY, A. K., Guffey, D., Balasubramanyam, A., REDONDO, M. J., & Tosur, M. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13329 · Cited by 7
“Given the predominantly autosomal dominant mode of inheritance, MODY often presents in a young individual with a family history of diabetes extending across several generations.(1,21,22) Multigenerational family history for our study was defined as having diabetes in at least three consecutive generations (e.”
BackgroundThe search for undiagnosed MODY patients: what is the next step?
Malecki, M. T. (2010) · Diabetologia · doi:10.1007/s00125-010-1908-4 · Cited by 7
“Individuals involved in MODY research revealed the origin of these differences and learnt how to use them in medical practice [2, 10–12].”
BackgroundIncorporating Type 1 Diabetes Prevention Into Clinical Practice
Gregory, J. M., Lilley, J. S., Misfeldt, A. A., Buscariollo, D. L., Russell, W. E., & Moore, D. J. (2010) · Clinical Diabetes · doi:10.2337/diaclin.28.2.61 · Cited by 6
Metadata
- Authors
- Murphy, R., Ellard, S., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- Corresponding author
- Hattersley, Andrew T
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-02-26
- Volume
- 4
- Issue
- 4
- Pages
- 200-213
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- OpenAlex
- W1996549380
- Semantic Scholar
- ca1487d43edc4a5abbe40904a2e6414a4534638e
- Cited by
- 502
- References
- 91
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 10 · 2023: 18 · 2022: 17 · 2021: 33 · 2020: 23 · 2019: 21 · 2018: 34 · 2017: 32 · 2016: 33 · 2015: 33 · 2014: 36 · 2013: 29 · 2012: 42
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- monogenic diabetes, maturity-onset diabetes of the young, neonatal diabetes, molecular genetic classification, Kir6.2, SUR1, sulfonylurea therapy, glucokinase mutations, HNF1A, HNF4α, HNF1B, genetic counseling, insulin therapy
- MeSH terms
- Kcnj11 Channel, Diabetes Mellitus, Diagnosis, Differential, Female, Glucokinase, Humans, Infant, Newborn, Male, Mutation, Receptors, Drug, Potassium Channels, ATP-Binding Cassette Transporters, Potassium Channels, Inwardly Rectifying, Insulin-Secreting Cells, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4, Sulfonylurea Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.